APO Research
Talk to an analyst

APO RESEARCH · REPORT

Closed System Drug Transfer Device (CSTD)

A closed system drug transfer device or "CSTD" is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A closed system drug transfer device or "CSTD" is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system

Selected research

Market Outlook & Growth Opportunities

Global Closed System Drug Transfer Device (CSTD) Market Outlook and Growth Opportunities 2026

21 December 2025192 pages

Choose your research edition.

Industry ResearchClosed System Drug Transfer Device (CSTD) Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Closed System Drug Transfer Device (CSTD) Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Closed System Drug Transfer Device (CSTD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Closed System Drug Transfer Device (CSTD) Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Closed System Drug Transfer Device (CSTD) Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

A closed system drug transfer device or "CSTD" is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system

Global Closed System Drug Transfer Device (CSTD) key players include BD Medical, Inc, Equashield, ICU Medical, etc. Global top three manufacturers hold a share over 80%.

North America is the largest market, with a share about 75%, followed by Europe and Japan, both have a share about 20 percent.

Read the full market overview

In terms of application, the largest application is Hospitals, followed by Clinics.

This report provides an overview of the global Closed System Drug Transfer Device (CSTD) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Closed System Drug Transfer Device (CSTD) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Closed System Drug Transfer Device (CSTD) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Closed System Drug Transfer Device (CSTD) market size, projected growth trends, production technologies, key applications, and end-use industries.

Closed System Drug Transfer Device (CSTD) Segment by Company

BD Medical

Equashield

ICU Medical

Simplivia Healthcare Ltd.

Corvida Medical

B. Braun

Closed System Drug Transfer Device (CSTD) Segment by Type

Closed Vial Access Devices

Closed Syringe Safety Devices

Closed Bag and Line Access Devices

Closed System Drug Transfer Device (CSTD) Segment by Application

Hospitals

Clinics

Closed System Drug Transfer Device (CSTD) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Closed System Drug Transfer Device (CSTD) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Closed System Drug Transfer Device (CSTD) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Closed System Drug Transfer Device (CSTD) significant trends, drivers, influence factors in global and regions.

6. To analyze Closed System Drug Transfer Device (CSTD) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Closed System Drug Transfer Device (CSTD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Closed System Drug Transfer Device (CSTD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Closed System Drug Transfer Device (CSTD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Closed System Drug Transfer Device (CSTD) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Closed System Drug Transfer Device (CSTD) industry.

Chapter 3: Detailed analysis of Closed System Drug Transfer Device (CSTD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Closed System Drug Transfer Device (CSTD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Closed System Drug Transfer Device (CSTD) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Closed System Drug Transfer Device (CSTD) Industry Trends Table 2. Closed System Drug Transfer Device (CSTD) Industry Drivers Table 3. Closed System Drug Transfer Device (CSTD) Industry Opportunities and Challenges Table 4. Closed System Drug Transfer Device (CSTD) Industry Restraints Table 5. Global Closed System Drug Transfer Device (CSTD) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Closed System Drug Transfer Device (CSTD) Revenue Share by Company (2021-2026) Table 7. Global Closed System Drug Transfer Device (CSTD) Sales Volume by Company (M Units) & (2021-2026) Table 8. Global Closed System Drug Transfer Device (CSTD) Sales Volume Share by Company (2021-2026) Table 9. Global Closed System Drug Transfer Device (CSTD) Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Closed System Drug Transfer Device (CSTD) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Closed System Drug Transfer Device (CSTD) Key Company Manufacturing Base & Headquarters Table 12. Global Closed System Drug Transfer Device (CSTD) Company, Product Type & Application Table 13. Global Closed System Drug Transfer Device (CSTD) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Closed System Drug Transfer Device (CSTD) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Closed Vial Access Devices Table 18. Significant Companies of Closed Syringe Safety Devices Table 19. Significant Companies of Closed Bag and Line Access Devices Table 20. Global Closed System Drug Transfer Device (CSTD) Sales Volume by Type 2021 VS 2025 VS 2032 (M Units) Table 21. Global Closed System Drug Transfer Device (CSTD) Sales Volume by Type (2021-2026) & (M Units) Table 22. Global Closed System Drug Transfer Device (CSTD) Sales Volume by Type (2027-2032) & (M Units) Table 23. Global Closed System Drug Transfer Device (CSTD) Sales Volume Share by Type (2021-2026) Table 24. Global Closed System Drug Transfer Device (CSTD) Sales Volume Share by Type (2027-2032) Table 25. Global Closed System Drug Transfer Device (CSTD) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Closed System Drug Transfer Device (CSTD) Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Closed System Drug Transfer Device (CSTD) Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Closed System Drug Transfer Device (CSTD) Sales Value Share by Type (2021-2026) Table 29. Global Closed System Drug Transfer Device (CSTD) Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospitals Table 31. Significant Companies of Clinics Table 32. Global Closed System Drug Transfer Device (CSTD) Sales Volume by Application 2021 VS 2025 VS 2032 (M Units) Table 33. Global Closed System Drug Transfer Device (CSTD) Sales Volume by Application (2021-2026) & (M Units) Table 34. Global Closed System Drug Transfer Device (CSTD) Sales Volume by Application (2027-2032) & (M Units) Table 35. Global Closed System Drug Transfer Device (CSTD) Sales Volume Share by Application (2021-2026) Table 36. Global Closed System Drug Transfer Device (CSTD) Sales Volume Share by Application (2027-2032) Table 37. Global Closed System Drug Transfer Device (CSTD) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Closed System Drug Transfer Device (CSTD) Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Closed System Drug Transfer Device (CSTD) Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Closed System Drug Transfer Device (CSTD) Sales Value Share by Application (2021-2026) Table 41. Global Closed System Drug Transfer Device (CSTD) Sales Value Share by Application (2027-2032) Table 42. Global Closed System Drug Transfer Device (CSTD) Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 43. Global Closed System Drug Transfer Device (CSTD) Sales by Region (2021-2026) & (M Units) Table 44. Global Closed System Drug Transfer Device (CSTD) Sales Market Share by Region (2021-2026) Table 45. Global Closed System Drug Transfer Device (CSTD) Sales by Region (2027-2032) & (M Units) Table 46. Global Closed System Drug Transfer Device (CSTD) Sales Market Share by Region (2027-2032) Table 47. Global Closed System Drug Transfer Device (CSTD) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Closed System Drug Transfer Device (CSTD) Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Closed System Drug Transfer Device (CSTD) Sales Value Share by Region (2021-2026) Table 50. Global Closed System Drug Transfer Device (CSTD) Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Closed System Drug Transfer Device (CSTD) Sales Value Share by Region (2027-2032) Table 52. Global Closed System Drug Transfer Device (CSTD) Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Closed System Drug Transfer Device (CSTD) Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Closed System Drug Transfer Device (CSTD) Sales by Country: 2021 VS 2025 VS 2032 (M Units) Table 55. Global Closed System Drug Transfer Device (CSTD) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Closed System Drug Transfer Device (CSTD) Sales by Country (2021-2026) & (M Units) Table 57. Global Closed System Drug Transfer Device (CSTD) Sales Market Share by Country (2021-2026) Table 58. Global Closed System Drug Transfer Device (CSTD) Sales by Country (2027-2032) & (M Units) Table 59. Global Closed System Drug Transfer Device (CSTD) Sales Market Share by Country (2027-2032) Table 60. Global Closed System Drug Transfer Device (CSTD) Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Closed System Drug Transfer Device (CSTD) Sales Value Market Share by Country (2021-2026) Table 62. Global Closed System Drug Transfer Device (CSTD) Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Closed System Drug Transfer Device (CSTD) Sales Value Market Share by Country (2027-2032) Table 64. BD Medical Company Information Table 65. BD Medical Business Overview Table 66. BD Medical Closed System Drug Transfer Device (CSTD) Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. BD Medical Closed System Drug Transfer Device (CSTD) Product Portfolio Table 68. BD Medical Recent Development Table 69. Equashield Company Information Table 70. Equashield Business Overview Table 71. Equashield Closed System Drug Transfer Device (CSTD) Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Equashield Closed System Drug Transfer Device (CSTD) Product Portfolio Table 73. Equashield Recent Development Table 74. ICU Medical Company Information Table 75. ICU Medical Business Overview Table 76. ICU Medical Closed System Drug Transfer Device (CSTD) Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. ICU Medical Closed System Drug Transfer Device (CSTD) Product Portfolio Table 78. ICU Medical Recent Development Table 79. Simplivia Healthcare Ltd. Company Information Table 80. Simplivia Healthcare Ltd. Business Overview Table 81. Simplivia Healthcare Ltd. Closed System Drug Transfer Device (CSTD) Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Simplivia Healthcare Ltd. Closed System Drug Transfer Device (CSTD) Product Portfolio Table 83. Simplivia Healthcare Ltd. Recent Development Table 84. Corvida Medical Company Information Table 85. Corvida Medical Business Overview Table 86. Corvida Medical Closed System Drug Transfer Device (CSTD) Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Corvida Medical Closed System Drug Transfer Device (CSTD) Product Portfolio Table 88. Corvida Medical Recent Development Table 89. B. Braun Company Information Table 90. B. Braun Business Overview Table 91. B. Braun Closed System Drug Transfer Device (CSTD) Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. B. Braun Closed System Drug Transfer Device (CSTD) Product Portfolio Table 93. B. Braun Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Closed System Drug Transfer Device (CSTD) Distributors List Table 97. Closed System Drug Transfer Device (CSTD) Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Closed System Drug Transfer Device (CSTD) Product Image Figure 2. Global Closed System Drug Transfer Device (CSTD) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Closed System Drug Transfer Device (CSTD) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Closed System Drug Transfer Device (CSTD) Sales (2021-2032) & (M Units) Figure 5. Global Closed System Drug Transfer Device (CSTD) Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Closed System Drug Transfer Device (CSTD) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Closed Vial Access Devices Image Figure 10. Closed Syringe Safety Devices Image Figure 11. Closed Bag and Line Access Devices Image Figure 12. Global Closed System Drug Transfer Device (CSTD) Sales Volume by Type (2021 VS 2025 VS 2032) & (M Units) Figure 13. Global Closed System Drug Transfer Device (CSTD) Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Closed System Drug Transfer Device (CSTD) Sales Volume Share by Type (2021-2032) Figure 15. Global Closed System Drug Transfer Device (CSTD) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Closed System Drug Transfer Device (CSTD) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Closed System Drug Transfer Device (CSTD) Sales Value Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Clinics Image Figure 20. Global Closed System Drug Transfer Device (CSTD) Sales Volume by Application (2021 VS 2025 VS 2032) & (M Units) Figure 21. Global Closed System Drug Transfer Device (CSTD) Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Closed System Drug Transfer Device (CSTD) Sales Volume Share by Application (2021-2032) Figure 23. Global Closed System Drug Transfer Device (CSTD) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Closed System Drug Transfer Device (CSTD) Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Closed System Drug Transfer Device (CSTD) Sales Value Share by Application (2021-2032) Figure 26. Global Closed System Drug Transfer Device (CSTD) Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 27. Global Closed System Drug Transfer Device (CSTD) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Closed System Drug Transfer Device (CSTD) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Closed System Drug Transfer Device (CSTD) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Closed System Drug Transfer Device (CSTD) Sales Value (2021-2032) & (US$ Million) Figure 31. North America Closed System Drug Transfer Device (CSTD) Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Closed System Drug Transfer Device (CSTD) Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Closed System Drug Transfer Device (CSTD) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Closed System Drug Transfer Device (CSTD) Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Closed System Drug Transfer Device (CSTD) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Closed System Drug Transfer Device (CSTD) Sales Value (2021-2032) & (US$ Million) Figure 37. South America Closed System Drug Transfer Device (CSTD) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Closed System Drug Transfer Device (CSTD) Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Closed System Drug Transfer Device (CSTD) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Closed System Drug Transfer Device (CSTD) Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Closed System Drug Transfer Device (CSTD) Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Closed Vial Access Devices
  • Closed Syringe Safety Devices
  • Closed Bag and Line Access Devices
Applications
  • Hospitals
  • Clinics
Companies covered
  • BD Medical
  • Equashield
  • ICU Medical
  • Simplivia Healthcare Ltd.
  • Corvida Medical
  • B. Braun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Closed System Drug Transfer Device (CSTD) Sales Value (2021-2032)
  4. 1.2.2 Global Closed System Drug Transfer Device (CSTD) Sales Volume (2021-2032)
  5. 1.2.3 Global Closed System Drug Transfer Device (CSTD) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Closed System Drug Transfer Device (CSTD) Market Dynamics
  1. 2.1 Closed System Drug Transfer Device (CSTD) Industry Trends
  2. 2.2 Closed System Drug Transfer Device (CSTD) Industry Drivers
  3. 2.3 Closed System Drug Transfer Device (CSTD) Industry Opportunities and Challenges
  4. 2.4 Closed System Drug Transfer Device (CSTD) Industry Restraints
3 Closed System Drug Transfer Device (CSTD) Market by Company
  1. 3.1 Global Closed System Drug Transfer Device (CSTD) Company Revenue Ranking in 2025
  2. 3.2 Global Closed System Drug Transfer Device (CSTD) Revenue by Company (2021-2026)
  3. 3.3 Global Closed System Drug Transfer Device (CSTD) Sales Volume by Company (2021-2026)
  4. 3.4 Global Closed System Drug Transfer Device (CSTD) Average Price by Company (2021-2026)
  5. 3.5 Global Closed System Drug Transfer Device (CSTD) Company Ranking (2024-2026)
  6. 3.6 Global Closed System Drug Transfer Device (CSTD) Company Manufacturing Base and Headquarters
  7. 3.7 Global Closed System Drug Transfer Device (CSTD) Company Product Type and Application
  8. 3.8 Global Closed System Drug Transfer Device (CSTD) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Closed System Drug Transfer Device (CSTD) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Closed System Drug Transfer Device (CSTD) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Closed System Drug Transfer Device (CSTD) Market by Type
  1. 4.1 Closed System Drug Transfer Device (CSTD) Type Introduction
  2. 4.1.1 Closed Vial Access Devices
  3. 4.1.2 Closed Syringe Safety Devices
  4. 4.1.3 Closed Bag and Line Access Devices
  5. 4.2 Global Closed System Drug Transfer Device (CSTD) Sales Volume by Type
  6. 4.2.1 Global Closed System Drug Transfer Device (CSTD) Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Closed System Drug Transfer Device (CSTD) Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Closed System Drug Transfer Device (CSTD) Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Closed System Drug Transfer Device (CSTD) Sales Value by Type
  10. 4.3.1 Global Closed System Drug Transfer Device (CSTD) Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Closed System Drug Transfer Device (CSTD) Sales Value by Type (2021-2032)
  12. 4.3.3 Global Closed System Drug Transfer Device (CSTD) Sales Value Share by Type (2021-2032)
5 Closed System Drug Transfer Device (CSTD) Market by Application
  1. 5.1 Closed System Drug Transfer Device (CSTD) Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.2 Global Closed System Drug Transfer Device (CSTD) Sales Volume by Application
  5. 5.2.1 Global Closed System Drug Transfer Device (CSTD) Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Closed System Drug Transfer Device (CSTD) Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Closed System Drug Transfer Device (CSTD) Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Closed System Drug Transfer Device (CSTD) Sales Value by Application
  9. 5.3.1 Global Closed System Drug Transfer Device (CSTD) Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Closed System Drug Transfer Device (CSTD) Sales Value by Application (2021-2032)
  11. 5.3.3 Global Closed System Drug Transfer Device (CSTD) Sales Value Share by Application (2021-2032)
6 Closed System Drug Transfer Device (CSTD) Regional Sales and Value Analysis
  1. 6.1 Global Closed System Drug Transfer Device (CSTD) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Closed System Drug Transfer Device (CSTD) Sales by Region (2021-2032)
  3. 6.2.1 Global Closed System Drug Transfer Device (CSTD) Sales by Region: 2021-2026
  4. 6.2.2 Global Closed System Drug Transfer Device (CSTD) Sales by Region (2027-2032)
  5. 6.3 Global Closed System Drug Transfer Device (CSTD) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Closed System Drug Transfer Device (CSTD) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Closed System Drug Transfer Device (CSTD) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Closed System Drug Transfer Device (CSTD) Sales Value by Region (2027-2032)
  9. 6.5 Global Closed System Drug Transfer Device (CSTD) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Closed System Drug Transfer Device (CSTD) Sales Value (2021-2032)
  12. 6.6.2 North America Closed System Drug Transfer Device (CSTD) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Closed System Drug Transfer Device (CSTD) Sales Value (2021-2032)
  15. 6.7.2 Europe Closed System Drug Transfer Device (CSTD) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Closed System Drug Transfer Device (CSTD) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Closed System Drug Transfer Device (CSTD) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Closed System Drug Transfer Device (CSTD) Sales Value (2021-2032)
  21. 6.9.2 South America Closed System Drug Transfer Device (CSTD) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Closed System Drug Transfer Device (CSTD) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Closed System Drug Transfer Device (CSTD) Sales Value Share by Country, 2025 VS 2032
7 Closed System Drug Transfer Device (CSTD) Country-level Sales and Value Analysis
  1. 7.1 Global Closed System Drug Transfer Device (CSTD) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Closed System Drug Transfer Device (CSTD) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Closed System Drug Transfer Device (CSTD) Sales by Country (2021-2032)
  4. 7.3.1 Global Closed System Drug Transfer Device (CSTD) Sales by Country (2021-2026)
  5. 7.3.2 Global Closed System Drug Transfer Device (CSTD) Sales by Country (2027-2032)
  6. 7.4 Global Closed System Drug Transfer Device (CSTD) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Closed System Drug Transfer Device (CSTD) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Closed System Drug Transfer Device (CSTD) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Closed System Drug Transfer Device (CSTD) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Closed System Drug Transfer Device (CSTD) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Closed System Drug Transfer Device (CSTD) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BD Medical
  2. 8.1.1 BD Medical Company Information
  3. 8.1.2 BD Medical Business Overview
  4. 8.1.3 BD Medical Closed System Drug Transfer Device (CSTD) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 BD Medical Closed System Drug Transfer Device (CSTD) Product Portfolio
  6. 8.1.5 BD Medical Recent Developments
  7. 8.2 Equashield
  8. 8.2.1 Equashield Company Information
  9. 8.2.2 Equashield Business Overview
  10. 8.2.3 Equashield Closed System Drug Transfer Device (CSTD) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Equashield Closed System Drug Transfer Device (CSTD) Product Portfolio
  12. 8.2.5 Equashield Recent Developments
  13. 8.3 ICU Medical
  14. 8.3.1 ICU Medical Company Information
  15. 8.3.2 ICU Medical Business Overview
  16. 8.3.3 ICU Medical Closed System Drug Transfer Device (CSTD) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 ICU Medical Closed System Drug Transfer Device (CSTD) Product Portfolio
  18. 8.3.5 ICU Medical Recent Developments
  19. 8.4 Simplivia Healthcare Ltd.
  20. 8.4.1 Simplivia Healthcare Ltd. Company Information
  21. 8.4.2 Simplivia Healthcare Ltd. Business Overview
  22. 8.4.3 Simplivia Healthcare Ltd. Closed System Drug Transfer Device (CSTD) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Simplivia Healthcare Ltd. Closed System Drug Transfer Device (CSTD) Product Portfolio
  24. 8.4.5 Simplivia Healthcare Ltd. Recent Developments
  25. 8.5 Corvida Medical
  26. 8.5.1 Corvida Medical Company Information
  27. 8.5.2 Corvida Medical Business Overview
  28. 8.5.3 Corvida Medical Closed System Drug Transfer Device (CSTD) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Corvida Medical Closed System Drug Transfer Device (CSTD) Product Portfolio
  30. 8.5.5 Corvida Medical Recent Developments
  31. 8.6 B. Braun
  32. 8.6.1 B. Braun Company Information
  33. 8.6.2 B. Braun Business Overview
  34. 8.6.3 B. Braun Closed System Drug Transfer Device (CSTD) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 B. Braun Closed System Drug Transfer Device (CSTD) Product Portfolio
  36. 8.6.5 B. Braun Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Closed System Drug Transfer Device (CSTD) Value Chain Analysis
  2. 9.1.1 Closed System Drug Transfer Device (CSTD) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Closed System Drug Transfer Device (CSTD) Sales Mode & Process
  6. 9.2 Closed System Drug Transfer Device (CSTD) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Closed System Drug Transfer Device (CSTD) Distributors
  9. 9.2.3 Closed System Drug Transfer Device (CSTD) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst